Queen's Awards Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

MK-7725

SKU: orb1696057

Description

Mk-7725 is a potent and selective agonist for the bombesin receptor subtype 3 (BRS-3), investigated as a potential therapeutic for obesity. Research applications include studying energy homeostasis and metabolic function through both in vitro receptor activation assays and in vivo models of diet-induced obesity.

Images & Validation

Key Properties

CAS Number1034152-95-8
MW615.5
FormulaC25H19F6N5O5S
SMILESS(=O)(=O)(N1C2=C(C=CC=C2NC=3C(C1)=CC=C(C(F)(F)F)N3)C=4N=C(C(C)(C)O)ON4)C5=CC=C(OC(F)(F)F)C=C5
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

MK-7725 (orb1696057)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%